<SEC-DOCUMENT>0000899243-20-031479-index.html : 20201118
<SEC-HEADER>0000899243-20-031479.hdr.sgml : 20201118
<ACCEPTANCE-DATETIME>20201118184656
ACCESSION NUMBER:		0000899243-20-031479
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20201118
FILED AS OF DATE:		20201118
DATE AS OF CHANGE:		20201118

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
		CENTRAL INDEX KEY:			0001787092
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39712
		FILM NUMBER:		201326515

	BUSINESS ADDRESS:	
		STREET 1:		WELLINGTON ALTERNATIVE INVESTMENTS LLC
		STREET 2:		280 CONGRESS STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(617) 951-5372

	MAIL ADDRESS:	
		STREET 1:		WELLINGTON ALTERNATIVE INVESTMENTS LLC
		STREET 2:		280 CONGRESS STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Olema Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001750284
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				300409740
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		512 2ND STREET, 4TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
		BUSINESS PHONE:		(415) 651-3316

	MAIL ADDRESS:	
		STREET 1:		512 2ND STREET, 4TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
Document 1 - file: doc3.html

Document 1 - RAW XML: doc3.xml

</DOCUMENT>
</SEC-DOCUMENT>